Louis C. Bock, Director, 10% Owner at Orexigen Therapeutics, Inc. (OREX), sold 14,813 shares at $15.50 ($230K) on 2007-11-15, disclosed to the SEC on 2007-11-16.
Open-market sale of $230k OREX by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.96 | 100 | $2K | 0.7% |
| 2 | $15.97 | 100 | $2K | 0.7% |
| 3 | $15.98 | 100 | $2K | 0.7% |
| 4 | $15.99 | 100 | $2K | 0.7% |
| 5 | $16.01 | 100 | $2K | 0.7% |
| 6 | $16.03 | 18 |
| $289 |
| 0.1% |
| 7 | $15.36 | 300 | $5K | 2.0% |
| 8 | $15.37 | 700 | $11K | 4.7% |
| 9 | $15.39 | 200 | $3K | 1.3% |
| 10 | $15.40 | 500 | $8K | 3.3% |
| 11 | $15.41 | 1,500 | $23K | 10.0% |
| 12 | $15.42 | 600 | $9K | 4.0% |
| 13 | $15.43 | 800 | $12K | 5.4% |
| 14 | $15.44 | 1,100 | $17K | 7.4% |
| 15 | $15.45 | 700 | $11K | 4.7% |
| 16 | $15.47 | 300 | $5K | 2.0% |
| 17 | $15.48 | 500 | $8K | 3.4% |
| 18 | $15.49 | 500 | $8K | 3.4% |
| 19 | $15.50 | 600 | $9K | 4.0% |
| 20 | $15.51 | 200 | $3K | 1.3% |
| 21 | $15.52 | 200 | $3K | 1.3% |
| 22 | $15.53 | 300 | $5K | 2.0% |
| 23 | $15.57 | 600 | $9K | 4.1% |
| 24 | $15.58 | 700 | $11K | 4.7% |
| 25 | $15.59 | 301 | $5K | 2.0% |
| 26 | $15.61 | 200 | $3K | 1.4% |
| 27 | $15.64 | 200 | $3K | 1.4% |
| 28 | $15.68 | 400 | $6K | 2.7% |
| 29 | $15.70 | 1,394 | $22K | 9.5% |
| 30 | $15.73 | 1,500 | $24K | 10.3% |
| Total | $15.54 avg | 14,813 | $230K | 100% |
| Filing → |
| OREX | BUY | 2014-11-13 | $151K | — | Filing → |
| ZGNX | BUY | 2011-09-22 | $2.5M | — | Filing → |
| HZNP | BUY | 2011-08-04 | $2.8M | — | Filing → |